Mena-Vázquez, N.; Redondo-RodrÃguez, R.; Rojas-Gimenez, M.; Romero-Barco, C.M.; Manrique-Arija, S.; Ortega-Castro, R.; Hidalgo Conde, A.; Arnedo DÃez de los RÃos, R.; Cabrera César, E.; Espildora, F.;
et al. Efficacy and Safety of Rituximab in Autoimmune Disease—Associated Interstitial Lung Disease: A Prospective Cohort Study. J. Clin. Med. 2022, 11, 927.
https://doi.org/10.3390/jcm11040927
AMA Style
Mena-Vázquez N, Redondo-RodrÃguez R, Rojas-Gimenez M, Romero-Barco CM, Manrique-Arija S, Ortega-Castro R, Hidalgo Conde A, Arnedo DÃez de los RÃos R, Cabrera César E, Espildora F,
et al. Efficacy and Safety of Rituximab in Autoimmune Disease—Associated Interstitial Lung Disease: A Prospective Cohort Study. Journal of Clinical Medicine. 2022; 11(4):927.
https://doi.org/10.3390/jcm11040927
Chicago/Turabian Style
Mena-Vázquez, Natalia, RocÃo Redondo-RodrÃguez, Marta Rojas-Gimenez, Carmen MarÃa Romero-Barco, Sara Manrique-Arija, Rafaela Ortega-Castro, Ana Hidalgo Conde, RocÃo Arnedo DÃez de los RÃos, Eva Cabrera César, Francisco Espildora,
and et al. 2022. "Efficacy and Safety of Rituximab in Autoimmune Disease—Associated Interstitial Lung Disease: A Prospective Cohort Study" Journal of Clinical Medicine 11, no. 4: 927.
https://doi.org/10.3390/jcm11040927
APA Style
Mena-Vázquez, N., Redondo-RodrÃguez, R., Rojas-Gimenez, M., Romero-Barco, C. M., Manrique-Arija, S., Ortega-Castro, R., Hidalgo Conde, A., Arnedo DÃez de los RÃos, R., Cabrera César, E., Espildora, F., Aguilar-Hurtado, M. C., Añón-Oñate, I., Pérez-Albaladejo, L., Abarca-Costalago, M., Ureña-Garnica, I., Velloso-Feijoo, M. L., Irigoyen-Oyarzábal, M. V., & Fernández-Nebro, A.
(2022). Efficacy and Safety of Rituximab in Autoimmune Disease—Associated Interstitial Lung Disease: A Prospective Cohort Study. Journal of Clinical Medicine, 11(4), 927.
https://doi.org/10.3390/jcm11040927
